Tvardi Therapeutics (TVRD) EBIT Margin (QoQ) (2013 - 2025)
Tvardi Therapeutics (TVRD) EBIT Margin (QoQ) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.50 Bn | 131.65 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.10 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.59 Bn | 60.41 Bn | 1.37 Bn |
| 4 | Moderna | 56.75 Bn | 51.62 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.64 Bn | 28.33 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.80 Bn | 9.41 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - |
| 10 | Tvardi Therapeutics | 17.36 Mn | 17.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 57,292.00 |
| Dec 31, 2024 | -52,034.00 |
| Sep 30, 2024 | 50,256.00 |
| Jun 30, 2024 | 66,489.00 |
| Mar 31, 2024 | -30,406.00 |
| Dec 31, 2023 | -49,158.00 |
| Sep 30, 2023 | -12,741.00 |
| Jun 30, 2023 | -1,797.00 |
| Mar 31, 2023 | 51,154.00 |
| Dec 31, 2022 | -73,952.00 |
| Sep 30, 2022 | -20,108.00 |
| Jun 30, 2022 | 56,325.00 |
| Mar 31, 2022 | 350,038.00 |
| Dec 31, 2021 | -407,752.00 |
| Mar 31, 2021 | -128,781.00 |
| Dec 31, 2020 | 25,387.00 |
| Sep 30, 2020 | 27,574.00 |
| Jun 30, 2020 | -8,872.00 |
| Sep 30, 2019 | -32,487.00 |
| Jun 30, 2019 | 32,136.00 |